Aclaris Therapeutics Inc
ACRS
$3.83+0.52%
End of day · as of Oct 23, 2026, 8:00 AM ET
Mkt cap
$615.92M
EV/Sales
76.2
P/E ratio
N/A
FY2025 Revenue
$7.83M
EPS (TTM)
$-0.58
Gross Margin (FY2025)
73.28%
Profit Margin (FY2025)
-829.58%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Latest reported ACRS revenue for 2025-12-31 was $7.8M. Net income was -$64.9M. Revenue was down 58.2% from 2024-12-31 to 2025-12-31. ACRS currently screens at market cap $615.9M.
Use this ACRS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ACRS income, balance, and cash tables.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company in the Healthcare sector.
Latest cached Aclaris Therapeutics Inc (ACRS) revenue for Dec 31, 2025 was $7.8M. Net income was -$64.9M. Statements: https://lician.com/financials/acrs
Aclaris Therapeutics Inc (ACRS) market capitalization is $615.9M on the latest cached snapshot.
Aclaris Therapeutics Inc (ACRS) cached previous close $3.81; day range $3.74 – $3.98; volume 2,798,194. Session quote: https://lician.com/quote/acrs
Aclaris Therapeutics Inc (ACRS) latest cached earnings event is "ACRS earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ACRS filing is 8-K · Aug 6, 2026. Filings: https://lician.com/sec/acrs